Literature DB >> 22712790

Comparable effect of recombinant and plasma-derived human fibrinogen concentrate on ex vivo clot formation after cardiac surgery.

V Radulovic, F Baghaei, I Fagerberg Blixter, S Samuelsson, A Jeppsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22712790     DOI： 10.1111/j.1538-7836.2012.04823.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  3 in total

1.  High-level expression and preparation of recombinant human fibrinogen as biopharmaceuticals.

Authors:  Masaki Hirashima; Takayuki Imamura; Kentaro Yano; Ryoichi Kawamura; Akihiro Meta; Yoshiyuki Tokieda; Toshihiro Nakashima
Journal:  J Biochem       Date:  2015-10-15       Impact factor: 3.387

2.  Hydrodynamic characterization of recombinant human fibrinogen species.

Authors:  Bertrand Raynal; Barbara Cardinali; Jos Grimbergen; Aldo Profumo; Susan T Lord; Patrick England; Mattia Rocco
Journal:  Thromb Res       Date:  2013-04-30       Impact factor: 3.944

Review 3.  Over 50 Years of Fibrinogen Concentrate.

Authors:  Rubens Costa-Filho; Gerald Hochleitner; Michael Wendt; Alexandre Teruya; Donat R Spahn
Journal:  Clin Appl Thromb Hemost       Date:  2015-08-19       Impact factor: 2.389
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.